Sotera Health Co. (SHC)
19.43
+0.45
(+2.37%)
USD |
NASDAQ |
Sep 16, 11:05
Sotera Health Enterprise Value : 7.328B for Sept. 15, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 15, 2026 | 7.328B |
| September 14, 2026 | 7.196B |
| September 11, 2026 | 7.153B |
| September 10, 2026 | 7.122B |
| September 09, 2026 | 7.142B |
| September 08, 2026 | 7.216B |
| September 04, 2026 | 7.305B |
| September 03, 2026 | 7.342B |
| September 02, 2026 | 7.322B |
| September 01, 2026 | 7.242B |
| August 31, 2026 | 7.305B |
| August 28, 2026 | 7.410B |
| August 27, 2026 | 7.470B |
| August 26, 2026 | 7.487B |
| August 25, 2026 | 7.479B |
| August 24, 2026 | 7.382B |
| August 21, 2026 | 7.496B |
| August 20, 2026 | 7.396B |
| August 19, 2026 | 7.333B |
| August 18, 2026 | 7.193B |
| August 17, 2026 | 7.276B |
| August 14, 2026 | 7.302B |
| August 13, 2026 | 7.339B |
| August 12, 2026 | 7.302B |
| August 11, 2026 | 7.365B |
| Date | Value |
|---|---|
| August 10, 2026 | 7.325B |
| August 07, 2026 | 7.293B |
| August 06, 2026 | 7.308B |
| August 05, 2026 | 7.042B |
| August 04, 2026 | 7.079B |
| August 03, 2026 | 7.045B |
| July 31, 2026 | 7.008B |
| July 30, 2026 | 7.005B |
| July 29, 2026 | 6.914B |
| July 28, 2026 | 6.979B |
| July 27, 2026 | 6.831B |
| July 24, 2026 | 6.862B |
| July 23, 2026 | 6.902B |
| July 22, 2026 | 6.845B |
| July 21, 2026 | 6.877B |
| July 20, 2026 | 6.882B |
| July 17, 2026 | 6.977B |
| July 16, 2026 | 7.125B |
| July 15, 2026 | 7.091B |
| July 14, 2026 | 6.982B |
| July 13, 2026 | 7.096B |
| July 10, 2026 | 7.168B |
| July 09, 2026 | 7.159B |
| July 08, 2026 | 6.897B |
| July 07, 2026 | 7.054B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Ginkgo Bioworks Holdings, Inc. | 523.41M |
| Myriad Genetics, Inc. | 466.23M |
| Natera, Inc. | 49.52B |
| Quest Diagnostics, Inc. | 33.32B |
| Labcorp Holdings, Inc. | 32.85B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 53.64M |
| Revenue (Quarterly) | 321.38M |
| Total Expenses (Quarterly) | 267.73M |
| EPS Diluted (Quarterly) | 0.1862 |
| Gross Profit Margin (Quarterly) | 54.44% |
| Profit Margin (Quarterly) | 16.69% |
| Earnings Yield | 2.93% |
| Operating Earnings Yield | 8.03% |
| Normalized Earnings Yield | 3.607 |